Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The hypoxia-inducible factor (HIF) family of transcription factors is responsible for coordinating the cellular response to low oxygen levels in animals. By regulating the expression of a large array of target genes during hypoxia, these proteins also direct adaptive changes in the hematopoietic, cardiovascular, and respiratory systems. They also play roles in pathological processes, including tumorogenesis. In recent years, several oxygenases have been identified as key molecular oxygen sensors within the HIF system. The HIF hydroxylases regulate the stability and transcriptional activity of the HIF-alpha subunit by catalyzing hydroxylation of specific proline and asparaginyl residues, respectively. They require oxygen and 2-oxoglutarate (2OG) as co-substrates, and depend upon non-heme ferrous iron (Fe(II)) as a cofactor. This article summarizes current understanding of the biochemistry of the HIF hydroxylases, identifies targets for their pharmacological manipulation, and discusses their potential in the therapeutic manipulation of the HIF system.

Original publication

DOI

10.1089/ars.2009.2711

Type

Journal article

Journal

Antioxid Redox Signal

Publication Date

04/2010

Volume

12

Pages

481 - 501

Keywords

Anemia, Animals, Brain Ischemia, Enzyme Inhibitors, Gastrointestinal Diseases, Humans, Hypertension, Pulmonary, Hypoxia-Inducible Factor 1, Iron, Iron Chelating Agents, Ketoglutaric Acids, Kidney Diseases, Mice, Myocardial Ischemia, N-substituted Glycines, Neoplasms, Oxalates, Oxygen, Procollagen-Proline Dioxygenase, Rats